Amedeo Smart

Free Medical Literature Service


 

Amedeo

Dyslipidemia

  Free Subscription

Articles published in
Metabolism
    November 2023
  1. ZUO F, Wang Y, Xu X, Ding R, et al
    CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
    Metabolism. 2023 Nov 10:155724. doi: 10.1016/j.metabol.2023.155724.
    >> Share

    July 2023
  2. WANG YD, Wu LL, Mai YN, Wang K, et al
    miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis.
    Metabolism. 2023 Jul 12:155660. doi: 10.1016/j.metabol.2023.155660.
    >> Share

    December 2022
  3. ZHANG J, Wu Y, Zhang J, Zhang R, et al
    ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease.
    Metabolism. 2022 Dec 12:155377. doi: 10.1016/j.metabol.2022.155377.
    >> Share

  4. HUANGFU G, Jaltotage B, Pang J, Lan NSR, et al
    Hepatic fat as a novel marker for high-risk coronary atherosclerotic plaque features in familial hypercholesterolaemia.
    Metabolism. 2022;139:155370.
    >> Share

    November 2022
  5. YE J, Zhuang X, Li X, Gong X, et al
    Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation.
    Metabolism. 2022;136:155294.
    >> Share

    October 2022
  6. LARSSON SC, Michaelsson K, Mola-Caminal M, Hoijer J, et al
    Genome-wide association and Mendelian randomization study of fibroblast growth factor 21 reveals causal associations with hyperlipidemia and possibly NASH.
    Metabolism. 2022;137:155329.
    >> Share

    September 2022
  7. TRICO D, Mengozzi A, Baldi S, Bizzotto R, et al
    Lipid-induced glucose intolerance is driven by impaired glucose kinetics and insulin metabolism in healthy individuals.
    Metabolism. 2022;134:155247.
    >> Share

    July 2022
  8. BOUZONI E, Perakakis N, Connelly MA, Angelidi AM, et al
    PCSK9 and ANGPTL3 levels correlate with hyperlipidemia in HIV-lipoatrophy, are regulated by fasting and are not affected by leptin administered in physiologic or pharmacologic doses.
    Metabolism. 2022 Jul 9:155265. doi: 10.1016/j.metabol.2022.155265.
    >> Share

    January 2022
  9. NEGI CK, Babica P, Bajard L, Bienertova-Vasku J, et al
    Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease.
    Metabolism. 2022;126:154925.
    >> Share

    December 2021
  10. BULLO M, Papandreou C, Garcia-Gavilan J, Ruiz-Canela M, et al
    Tricarboxylic acid cycle related-metabolites and risk of atrial fibrillation and heart failure.
    Metabolism. 2021;125:154915.
    >> Share

  11. HANA CA, Tran LV, Molzer C, Mullner E, et al
    Serum metabolomics analysis reveals increased lipid catabolism in mildly hyperbilirubinemic Gilbert's syndrome individuals.
    Metabolism. 2021;125:154913.
    >> Share

    November 2021
  12. YING Q, Chan DC, Barrett PHR, Watts GF, et al
    Unravelling lipoprotein metabolism with stable isotopes: tracing the flow.
    Metabolism. 2021;124:154887.
    >> Share

    July 2021
  13. LIU S, Wang J, Wu S, Niu J, et al
    The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis.
    Metabolism. 2021;120:154779.
    >> Share

    June 2021
  14. PICHE ME, Clavel MA, Auclair A, Rodriguez-Flores M, et al
    Early benefits of bariatric surgery on subclinical cardiac function: Contribution of visceral fat mobilization.
    Metabolism. 2021;119:154773.
    >> Share

    May 2021
  15. ALI S, Malloci M, Safiedeen Z, Soleti R, et al
    LPS-enriched small extracellular vesicles from metabolic syndrome patients trigger endothelial dysfunction by activation of TLR4.
    Metabolism. 2021;118:154727.
    >> Share

    March 2021
  16. XU X, Dong Y, Ma N, Kong W, et al
    MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice.
    Metabolism. 2021 Mar 25:154768. doi: 10.1016/j.metabol.2021.154768.
    >> Share

  17. ONG KL, McClelland RL, Allison MA, Cushman M, et al
    Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors.
    Metabolism. 2021;116:154706.
    >> Share

    February 2021
  18. NAKATSU Y, Yamamotoya T, Okumura M, Ishii T, et al
    Prolyl isomerase Pin1 interacts with adipose triglyceride lipase and negatively controls both its expression and lipolysis.
    Metabolism. 2021;115:154459.
    >> Share

  19. PICHE ME, Tardif I, Auclair A, Poirier P, et al
    Effects of bariatric surgery on lipid-lipoprotein profile.
    Metabolism. 2021;115:154441.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016